{"id":"https://openalex.org/W2554977553","doi":null,"title":"Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of Guidance No. 33) Addendum: Economic evaluation of irinotecan and oxaliplatin for the treatment of advanced colorectal cancer","display_name":"Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of Guidance No. 33) Addendum: Economic evaluation of irinotecan and oxaliplatin for the treatment of advanced colorectal cancer","alternate_titles":[],"publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2554977553","mag":"2554977553"},"language":"en","primary_location":{"id":"mag:2554977553","doi":null,"is_oa":false,"landing_page_url":"https://www.nice.org.uk/guidance/TA93/documents/colorectal-cancer-advanced-irinotecan-oxaliplatin-and-raltitrexed-review-assessment-report-economic-addendum2","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2554977553"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058139106","display_name":"Daniel Hind","orcid":"https://orcid.org/0000-0002-6409-4793","observed_orcids":["https://orcid.org/0000-0002-6409-4793"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel Hind","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061681421","display_name":"Paul Tappenden","orcid":"https://orcid.org/0000-0001-6612-2332","observed_orcids":["https://orcid.org/0000-0001-6612-2332"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Tappenden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021954458","display_name":"Indra Tumur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Indra Tumur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086238725","display_name":"Paul A Sutcliffe","orcid":"https://orcid.org/0000-0003-4198-4678","observed_orcids":["https://orcid.org/0000-0003-4198-4678"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Sutcliffe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Angie Ryan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Angie Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.4754,"has_fulltext":false,"cited_by_count":25,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96976914,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.08079999685287476,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9670000076293945},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":1.0},{"id":"https://openalex.org/keywords/raltitrexed","display_name":"raltitrexed","score":0.996999979019165},{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.828000009059906},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5649999976158142},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C2779268555","wikidata":"https://www.wikidata.org/wiki/Q15304877","display_name":"Raltitrexed","level":5,"score":0.9219948053359985},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.8822391629219055},{"id":"https://openalex.org/C2777352838","wikidata":"https://www.wikidata.org/wiki/Q5419420","display_name":"Excellence","level":2,"score":0.8512815237045288},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8466991782188416},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.730769157409668},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6499351859092712},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5388222932815552},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3800066411495209},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.32477328181266785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3065081834793091},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.266249418258667},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.2486695647239685},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.11224392056465149},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2554977553","doi":null,"is_oa":false,"landing_page_url":"https://www.nice.org.uk/guidance/TA93/documents/colorectal-cancer-advanced-irinotecan-oxaliplatin-and-raltitrexed-review-assessment-report-economic-addendum2","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1757970254","https://openalex.org/W2004341708","https://openalex.org/W2021399650","https://openalex.org/W2067482493","https://openalex.org/W2078369314","https://openalex.org/W2086256586","https://openalex.org/W2121368761","https://openalex.org/W2133399075","https://openalex.org/W2142750088","https://openalex.org/W2156462725"],"related_works":["https://openalex.org/W1757970254","https://openalex.org/W3208050502","https://openalex.org/W2142750088","https://openalex.org/W2049527041","https://openalex.org/W2026451919","https://openalex.org/W4210667753","https://openalex.org/W2065859474","https://openalex.org/W1977675372","https://openalex.org/W4247098235","https://openalex.org/W1500351560"],"abstract_inverted_index":{"Information":[0],"from":[1,31],"sponsors\u2019":[2],"and":[3],"academic":[4],"submissions":[5],"was":[6,19],"submitted":[7],"in":[8,39],"confidence":[9],"to":[10,22],"the":[11,23,35,40,44],"National":[12],"Institute":[13],"for":[14],"Clinical":[15],"Excellence,":[16],"this":[17,32,48],"information":[18],"made":[20],"available":[21],"NICE":[24],"Appraisals":[25],"Committee":[26],"but":[27],"has":[28,49],"been":[29],"removed":[30],"version":[33],"of":[34,43],"report.":[36],"A":[37],"note":[38],"relevant":[41],"portion":[42],"text":[45],"shows":[46],"where":[47],"occurred.":[50]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2554977553","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-11-30T00:00:00"}
